by Jane Butler, Royal College of Surgeons in Ireland (RCSI) A study led by researchers at RCSI (Royal College of Surgeons in Ireland) has identified a new genetic test that can be used to predict if a patient with epilepsy will develop an adverse reaction to a common anti-epileptic drug. The finding will help inform doctors […]
RCSI and Bayer have today announced a research collaboration that aims to improve treatments for people with severe haemophilia. The project will explore new treatments that can be tailored to the severity of each individual’s condition in order to safely and effectively promote blood clotting in people with haemophilia. Haemophilia is an inherited bleeding disorder […]
New treatment could ‘radically alter’ approach to condition An Irish college has discovered a new treatment that “significantly prevents” oesophageal cancer in patients predisposed to the disease following a trial that could “radically alter” medicine’s approach to the condition. The clinical trial spanning almost 20 years was spearheaded by Royal College of Surgeons in Ireland (RCSI) chief […]
Four RCSI investigators have participated in a landmark mental health study which has been published in Science. The study, ‘Analysis of shared heritability in common disorders of the brain‘, found that psychiatric disorders share an unexpected degree of common genetic risk. Dr Mark McCormack and Dr Christopher Whelan (Molecular & Cellular Therapeutics) and Professors Kieran Murphy […]
The Royal Institute of the Architects of Ireland (RIAI) has announced RCSI‘s 26 York Street as the winner of the Public Choice category at the RIAI Irish Architecture Awards 2018. The healthcare education facility, designed by Henry J Lyons, was announced as Ireland’s favourite building in advance of the annual awards which celebrate the important […]
Europe’s most advanced healthcare education facility has been officially opened in Dublin city. Based at the Royal College of Surgeons in Ireland (RCSI), 26 York Street aims to promote innovation in learning, delivering ‘world class medical and healthcare education’. According to the Minister for Education, Richard Bruton, this €80 million 10-floor facility ‘showcases the […]
Developing new treatments for childhood epilepsies and neuro-developmental diseases is the aim of a new partnership between RCSI (FutureNeuro, the SFI Research Centre for chronic and rare neurological diseases based at RCSI) and F. Hoffmann-La Roche Ltd. announced today. The three-year partnership aims to guide scientists to new gene targets to control some of the […]
RCSI has won the Best Education Outreach award and the Excellence in the Provision of Professional Services award at The Education Awards 2018. The Education Awards celebrate excellence in the third level education sector on the island of Ireland. The awards were presented at a ceremony held at the Ballsbridge Hotel in Dublin last night. […]
Over 350 children, aged between 4 – 10, brought their sick or injured teddies to the fourth annual RCSI (Royal College of Surgeons in Ireland) Teddy Bear Hospital on Saturday, 10 February and Sunday, 11 February in the College at 123 St Stephen’s Green. Hosted by medical, physiotherapy and pharmacy students in the RCSI Paediatrics […]
RCSI (Royal College of Surgeons in Ireland) is leading an international team of scientists on a major research study “COLOSSUS” which aims to provide new and more effective ways to classify and treat patients with colorectal cancer. The project will focus on colorectal cancer that has spread from the colon to other parts of the […]
A new €11 million three-storey extension to the Royal College of Surgeons in Ireland (RCSI) Education and Research Centre at Dublin’s Beaumont Hospital is due for completion in May this year. The facility represents the third phase of development for the education and research facilities of the RCSI at Beaumont Hospital. “The first phase was […]
A novel clinical study called “The Irish Personalized Approach to the Treatment of Hemophilia (iPATH)” will seek to investigate the potential of new personalized treatment approaches in hemophilia by tailoring care based on the needs of individual patients. The collaborative study will be led by the Irish Hemophilia Society, in partnership with Shire, a global biotech company that specializes in […]
Copyright ©️ 2016–2024
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.